In Silico

1.
Alexandra Maertens, Thomas Luechtefeld, Jean Knight, Thomas Hartung. Alternative methods go green! Green toxicology as a sustainable approach for assessing chemical safety and designing safer chemicals. ALTEX. 2024;41(1):3-19. doi:10.14573/altex.2312291
View Full Reference
1.
Madura KP Jayatunga, Margaret Ayers, Lotte Bruens, Dhruv Jayanth, Christoph Meier. How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons. Drug Discovery Today. 2024;29(6):104009. doi:10.1016/j.drudis.2024.104009
View Full Reference
1.
Danilo Bzdok, Andrew Thieme, Oleksiy Levkovskyy, Paul Wren, Thomas Ray, Siva Reddy. Data science opportunities of large language models for neuroscience and biomedicine. Neuron. 2024. doi:10.1016/j.neuron.2024.01.016
View Full Reference
1.
Thomas Hartung. ToxAIcology - The evolving role of artificial intelligence in advancing toxicology and modernizing regulatory science. ALTEX. 2023;40(4):559-570. doi:10.14573/altex.2309191
View Full Reference
1.
Rizwan Qureshi, Muhammad Irfan, Taimoor Muzaffar Gondal, et al. AI in drug discovery and its clinical relevance. Heliyon. 2023;9(7). doi:10.1016/j.heliyon.2023.e17575
View Full Reference
1.
Weihai Ying. Phenomic Studies on Diseases: Potential and Challenges. Phenomics. 2023;3(3):285-299. doi:10.1007/s43657-022-00089-4
View Full Reference
1.
Breanne Kincaid, Przemyslaw Piechota, Emily Golden, Mikhail Maertens, Thomas Hartung, Alexandra Maertens. Using in silico tools to predict flame retardant metabolites for more informative exposomics-based approaches. Frontiers in Toxicology. 2023;5:1216802. doi:10.3389/ftox.2023.1216802
View Full Reference
1.
Thomas Hartung. Artificial intelligence as the new frontier in chemical risk assessment. Frontiers in Artificial Intelligence. 2023;6:1269932. doi:10.3389/frai.2023.1269932
View Full Reference
1.
José Ramón Gutiérrez-Casares, Javier Quintero, Cristina Segú-Vergés, et al. In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population. Frontiers in Psychiatry. 2023;14:939650. doi:10.3389/fpsyt.2023.939650
View Full Reference
1.
Pauric Bannigan, Zeqing Bao, Riley J. Hickman, et al. Machine learning models to accelerate the design of polymeric long-acting injectables. Nature Communications. 2023;14(1):35. doi:10.1038/s41467-022-35343-w
View Full Reference